Wave Life Sciences
72 hedge funds and large institutions have $303M invested in Wave Life Sciences in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 16 closing their positions.
232% more call options, than puts
Call options by funds: $428K | Put options by funds: $129K
71% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 17
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 75 → 72 (-3)
6.99% less ownership
Funds ownership: 78.39% → 71.4% (-7%)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
36% less capital invested
Capital invested by funds: $477M → $303M (-$173M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$11.8M |
| 2 |
MCM
M28 Capital Management
Stamford,
Connecticut
|
+$4.8M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2.34M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.88M |
| 5 |
Jane Street
New York
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
-$6.78M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.16M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.33M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$2.3M |
| 5 |
CC
Casdin Capital
New York
|
-$1.4M |
WVE Hedge Fund Activity: Q1 2023 in Review
72 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2023, worth a combined $303M — down 36% from $477M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of WVE and 13 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 29 added.
The largest buyer was Kynam Capital Management, adding an estimated $11.8M. The largest seller was Davidson Kempner Capital Management, exiting entirely with an estimated $6.78M sold.
- 72 institutional investors held Wave Life Sciences (WVE) as of Q1 2023, down from 75 in Q4 2022.
- Funds reported $303M of Wave Life Sciences stock for Q1 2023, down 36% quarter-over-quarter.
- 13 funds opened new Wave Life Sciences positions in Q1 2023 and 16 closed out, a net change of -3 holders.
- The largest Wave Life Sciences buyer in Q1 2023 was Kynam Capital Management, an estimated $11.8M added.
- The largest Wave Life Sciences seller in Q1 2023 was Davidson Kempner Capital Management, an estimated $6.78M sold.
Based on aggregated 13F filings for Q1 2023.